Kerstin Mezger

graph of relations

Publications

  1. 2022
  2. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial

    Mezger, K., Ebert, S., Muhle, H. E., Stadt, U. Z., Borkhardt, A., Dilloo, D., Faber, J., Feuchtinger, T., Imschweiler, T., Jorch, N., Pekrun, A., Schmid, I., Schramm, F., Zimmermann, M., Horstmann, M. A. & Escherich, G., 12.2022, In: PEDIATR BLOOD CANCER. 69, 12, e29997.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review